amlodipin winthrop 10 mg tabletti
winthrop medicaments - amlodipini maleas - tabletti - 10 mg - amlodipiini
fluconazol winthrop 50 mg kapseli, kova
winthrop medicaments - fluconazolum - kapseli, kova - 50 mg - flukonatsoli
fluconazol winthrop 100 mg kapseli, kova
winthrop medicaments - fluconazolum - kapseli, kova - 100 mg - flukonatsoli
fluconazol winthrop 150 mg kapseli, kova
winthrop medicaments - fluconazolum - kapseli, kova - 150 mg - flukonatsoli
meloxicam winthrop 7.5 mg tabletti
winthrop medicaments - meloxicamum - tabletti - 7.5 mg - meloksikaami
meloxicam winthrop 15 mg tabletti
winthrop medicaments - meloxicamum - tabletti - 15 mg - meloksikaami
oxaliplatin winthrop 5 mg/ml infuusiokuiva-aine, liuosta varten
winthrop medicaments - oxaliplatinum - infuusiokuiva-aine, liuosta varten - 5 mg/ml - oksaliplatiini
oxaliplatin winthrop 5 mg/ml infuusiokonsentraatti, liuosta varten
winthrop medicaments - oxaliplatinum - infuusiokonsentraatti, liuosta varten - 5 mg/ml - oksaliplatiini
hemangiol
pierre fabre medicament - propranololihydrokloridia - hemangioma - beeta-estäjät - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
dalcipran 25 mg kapseli, kova
pierre fabre medicament - milnaciprani hydrochloridum - kapseli, kova - 25 mg - milnasipraani